Literature DB >> 25475624

[Vulvar diseases].

M Peckruhn1, P Elsner.   

Abstract

Vulvar diseases might cause problems in the differential diagnosis, because the clinical presentation of inflammatory, infectious and neoplastic disorders may be quite similar. Itching and pain as well as dysuria and dyspareunia are the most common symptoms of vulvar diseases. Inflammatory dermatoses like atopic and contact dermatitis, lichen planus, lichen sclerosus and atrophic vulvitis account for the majority of cases in specialized clinics. Furthermore, neoplastic conditions such as vulvar carcinoma, vulvar intraepithelial neoplasia (VIN) and vulvar Paget's disease have to be considered. Another frequent group are infections. Candida spp., herpes simplex viruses and human papilloma viruses are common pathogens. Additionally, vulvodynia is a typical problem that is sometimes difficult to treat. Because of the wide spectrum of clinical symptoms, cooperation with gynaecologists and psychosomatic specialists should be considered in difficult cases. The typical clinical presentations, their specific signs and symptoms, and pitfalls in the dermatological consultation are discussed.

Entities:  

Mesh:

Year:  2015        PMID: 25475624     DOI: 10.1007/s00105-014-3552-2

Source DB:  PubMed          Journal:  Hautarzt        ISSN: 0017-8470            Impact factor:   0.751


  31 in total

Review 1.  Topical interventions for genital lichen sclerosus.

Authors:  Ching-Chi Chi; Gudula Kirtschig; Maha Baldo; Fabia Brackenbury; Fiona Lewis; Fenella Wojnarowska
Journal:  Cochrane Database Syst Rev       Date:  2011-12-07

2.  Coexistence of lichen sclerosus and morphea: a retrospective analysis of 472 patients with localized scleroderma from a German tertiary referral center.

Authors:  Alexander Kreuter; Jana Wischnewski; Sarah Terras; Peter Altmeyer; Markus Stücker; Thilo Gambichler
Journal:  J Am Acad Dermatol       Date:  2012-04-24       Impact factor: 11.527

3.  Prevalence and impact of vaginal symptoms among postmenopausal women.

Authors:  Nanette Santoro; Janne Komi
Journal:  J Sex Med       Date:  2009-06-01       Impact factor: 3.802

Review 4.  Individualizing treatment and choice of medication in lichen planus: a step by step approach.

Authors:  Ioannis Manousaridis; Kleanthis Manousaridis; Wiebke Katharina Peitsch; Stefan Werner Schneider
Journal:  J Dtsch Dermatol Ges       Date:  2013-08-26       Impact factor: 5.584

Review 5.  Topical calcineurin inhibitors for the treatment of vulvar dermatoses.

Authors:  Andrew T Goldstein; Diamant Thaçi; Thomas Luger
Journal:  Eur J Obstet Gynecol Reprod Biol       Date:  2009-07-23       Impact factor: 2.435

Review 6.  Genital herpes.

Authors:  Lisa M Hollier; Heather Straub
Journal:  BMJ Clin Evid       Date:  2011-04-15

7.  Herpes simplex virus type 1 genital herpes in young women: current trend in Northern Finland.

Authors:  Hanna Tuokko; Risto Bloigu; Veijo Hukkanen
Journal:  Sex Transm Infect       Date:  2014-01-15       Impact factor: 3.519

8.  Prevalence and demographic characteristics of vulvodynia in a population-based sample.

Authors:  Barbara Diane Reed; Siobán Denise Harlow; Ananda Sen; Laurie Jo Legocki; Rayna Monique Edwards; Nora Arato; Hope Katharine Haefner
Journal:  Am J Obstet Gynecol       Date:  2011-08-22       Impact factor: 8.661

9.  Vulvar pruritus and burning sensation in women with psoriasis.

Authors:  Aleksandra Zamirska; Adam Reich; Joanna Berny-Moreno; Joanna Salomon; Jacek C Szepietowski
Journal:  Acta Derm Venereol       Date:  2008       Impact factor: 4.437

10.  A double-blind, randomized prospective study evaluating topical clobetasol propionate 0.05% versus topical tacrolimus 0.1% in patients with vulvar lichen sclerosus.

Authors:  Deana Funaro; Audrey Lovett; Nathalie Leroux; Julie Powell
Journal:  J Am Acad Dermatol       Date:  2014-04-03       Impact factor: 11.527

View more
  1 in total

1.  Most frequent dermatoses at a vulvar pathology outpatient clinic.

Authors:  Gabriella Cerazi Sartori; Rafaela Tricca Wicher; Flávia Regina Ferreira; Valéria Holmo Batista
Journal:  An Bras Dermatol       Date:  2018-03       Impact factor: 1.896

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.